Full Article in the Frontiers research topic: "Adverse Reactions to Biomaterials: State of the Art in Biomaterial Risk Assessment, Immunomodulation and In Vitro Models for Biomaterial Testing":
After the first 6 month of the project, the PANBioRA consortium has achieved significant steps towards the development of a integrated testing method for biomaterials.
From 9th-10th July the 17 PANBioRA partners met in Belgrade for the M6 project meeting. Every work package leader presented the activities performed in the first 6 months and the planned work for the...
PANBioRA's scientific coordinator Dr. Nihal Engin Vrana edited the book Biomaterials and Immune Response Complications, Mechanisms and Immunomodulation by CRC Press. Get keen insights into...
3D printing is not only influencing the industrial field but also leading to innovations and progress in clinical applications, e.g. in form of personalized implantable devices.
The first review...
The EU-funded project PANBioRA - Personalised And/or Generalised Integrated Biomaterial Risk Assessment has kicked off in January 2018. For the next four years, 17 project partners will collaborate to...
The 21st IEEE International Conference on BioInformatics and BioEngineering will take place as a hybrid event in Kragujevac, Serbia October 25-27, 2021
Meet us at TERMIS 2021, the international congress for Tissue Engineering and Regenerative Medecine
Meet our scientific coordinator Spartha at MEDICA 2021 in Düsseldorf, Germany
Regenerative Medicine International Society (TERMIS) European Chapter Meeting 2020